Key result
Splicing-dependent modulation of CaV1.3 channels alters electrophysiology to highlight potential targets for neurological diseases.
Should not yet inform practice; leaves open CaV1.3 splicing as a neurological therapeutic target pending validation.
To understand how splicing factors regulate alternative splicing (AS) of the voltage-gated calcium channel (VGCC) CaV1.3 and whether AS modifies its electrophysiological properties.
No takes yet. Share an insight, caveat, or question.
Rahman et al. (2026) studied this question. Splicing-dependent modulation of CaV1.3 calcium channels alters their electrophysiological properties, highlighting potential therapeutic targets for neurological diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: